Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Recombinant human activated protein C.

Martin Hughes¹

¹Intensive Care Medicine, Royal Infirmary, Glasgow G2 4AQ, UK. martinhughes@aol.com

International Journal of Antimicrobial Agents

|July 14, 2006

Summary

This review covers sepsis pathophysiology and the use of recombinant human activated protein C (rhAPC). It examines evidence for and against rhAPC and offers administration recommendations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

On context specificity and management reasoning: moving beyond diagnosis.

Diagnosis (Berlin, Germany)·2025

Same author

The Clinical Frailty Scale can be used retrospectively to assess the frailty of patients with hip fracture: a validation study.

European geriatric medicine·2022

Same author

Virtual Wards: A Rapid Adaptation to Clinical Attachments in MBChB During the COVID-19 Pandemic.

Advances in experimental medicine and biology·2022

Same author

The influence of different aspects of grouse moorland management on nontarget bird assemblages.

Ecology and evolution·2019

Same author

Safety of Extubating Mechanically Ventilated Patients Receiving Vasoactive Infusions: A Retrospective Cohort Study.

American journal of respiratory and critical care medicine·2018

Same author

CowPI: A Rumen Microbiome Focussed Version of the PICRUSt Functional Inference Software.

Frontiers in microbiology·2018

Area of Science:

Critical care medicine
Hematology
Pharmacology

Background:

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection.
Recombinant human activated protein C (rhAPC) has been investigated as a therapeutic agent for sepsis.
Understanding sepsis pathophysiology is crucial for developing effective treatments.

Purpose of the Study:

To review the pathophysiology of sepsis.
To evaluate the rationale and evidence for using rhAPC in sepsis treatment.
To provide evidence-based recommendations for rhAPC administration.

Main Methods:

Literature review of sepsis pathophysiology.
Analysis of clinical trial data on rhAPC efficacy and safety.
Synthesis of evidence to formulate recommendations.

Main Results:

The review details the complex pathophysiology of sepsis, including inflammatory and procoagulant pathways.
Evidence for rhAPC's benefits in sepsis is conflicting, with some studies showing potential advantages and others indicating risks.
Safety concerns and specific patient subgroups influence rhAPC's clinical utility.

Conclusions:

The use of rhAPC in sepsis requires careful consideration of the evidence and patient-specific factors.
Further research may clarify the role of rhAPC in specific sepsis contexts.
Evidence-based guidelines are essential for appropriate rhAPC administration.

Related Experiment Videos